ArticleThe Journal of clinical investigation2024

Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation.

Magnus T Dillon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.